173 related articles for article (PubMed ID: 12514953)
1. In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
Abdala H; Alvarez N; Delmas F; Di Giorgio C; Robert JM; Le Baut G; Le Pape P
Parasite; 2002 Dec; 9(4):367-70. PubMed ID: 12514953
[TBL] [Abstract][Full Text] [Related]
2. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antileishmanial activity of new 1-(pyridin-2-yl)imidazolidin-2-ones derived from 2-amino-4,6-dimethylpyridine.
Abdala H; Robert JM; Le Pape P; Wielgosz G; Robert-Piessard S; Le Baut G
Arzneimittelforschung; 2000 May; 50(5):479-84. PubMed ID: 10858876
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
7. Microtubule target for new antileishmanial drugs based on ethyl 3-haloacetamidobenzoates.
Hiam A; Sebastien D; George B; Arlette F; Kalil J; Le Pape P
J Enzyme Inhib Med Chem; 2006 Jun; 21(3):305-12. PubMed ID: 16918078
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana.
Hernández-Chinea C; Carbajo E; Sojo F; Arvelo F; Kouznetsov VV; Romero-Bohórquez AR; Romero PJ
Parasitol Int; 2015 Dec; 64(6):479-83. PubMed ID: 26148815
[TBL] [Abstract][Full Text] [Related]
9. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
Romero AH; Rodríguez N; Oviedo H; Lopez SE
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Antileishmanial Activity of Thioridazine.
Sifontes-Rodríguez S; Mollineda-Diogo N; Monzote-Fidalgo L; Escalona-Montaño AR; Escario García-Trevijano JA; Aguirre-García MM; Meneses-Marcel A
Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
12. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activities and mechanisms of action of indole-based azoles.
Pagniez F; Abdala-Valencia H; Marchand P; Le Borgne M; Le Baut G; Robert-Piessard S; Le Pape P
J Enzyme Inhib Med Chem; 2006 Jun; 21(3):277-83. PubMed ID: 16918075
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
[TBL] [Abstract][Full Text] [Related]
15. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
[TBL] [Abstract][Full Text] [Related]
16. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.
Al-Mohammed HI; Chance ML; Bates PA
Antimicrob Agents Chemother; 2005 Aug; 49(8):3274-80. PubMed ID: 16048936
[TBL] [Abstract][Full Text] [Related]
19. The leishmanicidal effect of (3S)-16,17-didehydrofalcarinol, an oxylipin isolated from Tridax procumbens, is independent of NO production.
Martín-Quintal Z; del Rosario García-Miss M; Mut-Martín M; Matus-Moo A; Torres-Tapia LW; Peraza-Sánchez SR
Phytother Res; 2010 Jul; 24(7):1004-8. PubMed ID: 19953523
[TBL] [Abstract][Full Text] [Related]
20. N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.
Stefanello TF; Panice MR; Ueda-Nakamura T; Sarragiotto MH; Auzély-Velty R; Nakamura CV
Antimicrob Agents Chemother; 2014 Dec; 58(12):7112-20. PubMed ID: 25224005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
